December 16, 2014 | The Israeli medical cannabis company One World Cannabis (OWC) is set to be traded over the counter on Wall Street. The company, which specializes in the research and development of cannabis-based treatments for diseases and medical conditions. The announcement comes following a reverse merger with Dynamic Applications, with OWC now owning 53 percent of the merged company. OWC’s cannabis treatments are tailored to specially treat and target a variety of conditions, such as diabetes, Parkinson’s disease, epilepsy and others. The company has plans to establish a non-profit organization that would work to support patients who are interested or already use medical cannabis. OWC’s scientific team is led by Dr. Alan Shackelford, an expert in the field of medical marijuana.